Nature Communications:科学家开发新方法将健康人类神经细胞注入大脑

2016-03-21 佚名 生物谷

罗格斯大学和斯坦福大学的科学家们创造出一种新技术,未来可能帮助治疗帕金森病和其他影响数百万人的毁灭性大脑相关疾病。 罗格斯大学生物医学工程系和化学与生化工程系特聘教授Prabhas V. Moghe表示,这种创新技术涉及将成人组织-衍生的干细胞在三维纤维"支架"或微小岛状物上转化为人类神经元。 这些装载健康、有益的神经元的支架,在被注入小鼠大脑后,能够替换病变细胞。 "如果你能以一种模拟细胞

罗格斯大学和斯坦福大学的科学家们创造出一种新技术,未来可能帮助治疗帕金森病和其他影响数百万人的毁灭性大脑相关疾病。

罗格斯大学生物医学工程系和化学与生化工程系特聘教授Prabhas V. Moghe表示,这种创新技术涉及将成人组织-衍生的干细胞在三维纤维"支架"或微小岛状物上转化为人类神经元。

这些装载健康、有益的神经元的支架,在被注入小鼠大脑后,能够替换病变细胞。

"如果你能以一种模拟细胞如何在大脑中被配置的方式来移植这些细胞,那么就更可能使大脑与你所移植的细胞进行沟通交流"Moghe说,"在这项工作中,我们通过为神经元提供快速形成三维网络的线索来实现这一点。"

在这项最新在线发表于《Nature Communications》的多学科研究中,罗格斯大学和斯坦福大学的科学家团队讨论了这种三维支架和它们潜在的广泛效益。

神经元或神经细胞,对人体的健康和功能至关重要。人类大脑拥有约1000亿个神经元,作为信使在大脑和身体之间传递信号。

Moghe表示,他们所开发的三维支架由微小的聚合物纤维构成。数以百计的神经元附着在这些纤维上并向外扩张,发送它们的信号。这些支架大约100微米宽,与人类头发的宽度大致相当。

"我们获得一整束这些岛状物,然后将它们注入到小鼠大脑中"他说,"这些植入大脑的神经元生存得出乎意料的好。事实上,它们的生存状况比该领域的黄金标准要好得多。"

这种支架技术所增加的细胞存活是其他方法的100倍以上,Moghe说道。

这可能最终帮助治疗帕金森病、多发性硬化、肌萎缩侧索硬化(ALS)、阿尔茨海默病、脊髓和创伤性脑损伤以及脑震荡,他说。

这些疾病通常是由大脑细胞丢失引起的。例如,帕金森病是由产生多巴胺的脑细胞丢失而导致的。脑细胞丢失会导致手部、手部、腿部、下巴和面部颤抖,四肢和躯干僵硬,运动缓慢以及平衡和协调性损害。

接下来将是进一步改进支架生物材料,使科学家们能够增加植入神经元的数量。"我们能够移植的神经元越多,为疾病带来的疗法益处就越大"Moghe说,"我们想在尽可能小的空间里填充尽可能多的神经元。"

想法是"创建一个不仅能高度运转而且能更好控制的非常密集的神经元回路"他说,并且补充道,针对帕金森病小鼠的试验正在进行中,查看它们能否获得改善或恢复。

最终,随着研究推进,研究人员将会在人类中进行研究。Moghe估计该技术推进到人类测试需要10到20年。

开发支架技术和在支架中重新编程干细胞是"非常辛苦的团队工作"他说,"我们已经研究了许多年,还需要付出大量的汗水和辛劳。"

原始出处:

Aaron L. Carlson,Neal K. Bennett,Nicola L. Francis,etal.Generation and transplantation of reprogrammed human neurons in the brain using 3D microtopographic scaffolds.Nature Communications.17 March 2016.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1911090, encodeId=3b58191109049, content=<a href='/topic/show?id=8c0d2e73196' target=_blank style='color:#2F92EE;'>#健康人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27731, encryptionId=8c0d2e73196, topicName=健康人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55f6293, createdName=lishizhe, createdTime=Sun Apr 10 22:02:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086852, encodeId=36d520868523f, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Jan 27 01:02:00 CST 2017, time=2017-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903120, encodeId=d10a19031202f, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Sun Jun 12 16:02:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880968, encodeId=aa4d18809684f, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Apr 25 13:02:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489525, encodeId=fcf61489525a7, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Mar 23 04:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573391, encodeId=fab415e33916c, content=<a href='/topic/show?id=28f4125430b' target=_blank style='color:#2F92EE;'>#Nature Communications#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12543, encryptionId=28f4125430b, topicName=Nature Communications)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bea15872676, createdName=qindq, createdTime=Wed Mar 23 04:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1911090, encodeId=3b58191109049, content=<a href='/topic/show?id=8c0d2e73196' target=_blank style='color:#2F92EE;'>#健康人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27731, encryptionId=8c0d2e73196, topicName=健康人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55f6293, createdName=lishizhe, createdTime=Sun Apr 10 22:02:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086852, encodeId=36d520868523f, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Jan 27 01:02:00 CST 2017, time=2017-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903120, encodeId=d10a19031202f, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Sun Jun 12 16:02:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880968, encodeId=aa4d18809684f, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Apr 25 13:02:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489525, encodeId=fcf61489525a7, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Mar 23 04:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573391, encodeId=fab415e33916c, content=<a href='/topic/show?id=28f4125430b' target=_blank style='color:#2F92EE;'>#Nature Communications#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12543, encryptionId=28f4125430b, topicName=Nature Communications)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bea15872676, createdName=qindq, createdTime=Wed Mar 23 04:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=)]
    2017-01-27 liuli5079
  3. [GetPortalCommentsPageByObjectIdResponse(id=1911090, encodeId=3b58191109049, content=<a href='/topic/show?id=8c0d2e73196' target=_blank style='color:#2F92EE;'>#健康人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27731, encryptionId=8c0d2e73196, topicName=健康人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55f6293, createdName=lishizhe, createdTime=Sun Apr 10 22:02:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086852, encodeId=36d520868523f, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Jan 27 01:02:00 CST 2017, time=2017-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903120, encodeId=d10a19031202f, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Sun Jun 12 16:02:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880968, encodeId=aa4d18809684f, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Apr 25 13:02:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489525, encodeId=fcf61489525a7, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Mar 23 04:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573391, encodeId=fab415e33916c, content=<a href='/topic/show?id=28f4125430b' target=_blank style='color:#2F92EE;'>#Nature Communications#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12543, encryptionId=28f4125430b, topicName=Nature Communications)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bea15872676, createdName=qindq, createdTime=Wed Mar 23 04:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1911090, encodeId=3b58191109049, content=<a href='/topic/show?id=8c0d2e73196' target=_blank style='color:#2F92EE;'>#健康人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27731, encryptionId=8c0d2e73196, topicName=健康人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55f6293, createdName=lishizhe, createdTime=Sun Apr 10 22:02:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086852, encodeId=36d520868523f, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Jan 27 01:02:00 CST 2017, time=2017-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903120, encodeId=d10a19031202f, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Sun Jun 12 16:02:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880968, encodeId=aa4d18809684f, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Apr 25 13:02:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489525, encodeId=fcf61489525a7, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Mar 23 04:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573391, encodeId=fab415e33916c, content=<a href='/topic/show?id=28f4125430b' target=_blank style='color:#2F92EE;'>#Nature Communications#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12543, encryptionId=28f4125430b, topicName=Nature Communications)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bea15872676, createdName=qindq, createdTime=Wed Mar 23 04:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=)]
    2016-04-25 liye789132251
  5. [GetPortalCommentsPageByObjectIdResponse(id=1911090, encodeId=3b58191109049, content=<a href='/topic/show?id=8c0d2e73196' target=_blank style='color:#2F92EE;'>#健康人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27731, encryptionId=8c0d2e73196, topicName=健康人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55f6293, createdName=lishizhe, createdTime=Sun Apr 10 22:02:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086852, encodeId=36d520868523f, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Jan 27 01:02:00 CST 2017, time=2017-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903120, encodeId=d10a19031202f, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Sun Jun 12 16:02:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880968, encodeId=aa4d18809684f, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Apr 25 13:02:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489525, encodeId=fcf61489525a7, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Mar 23 04:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573391, encodeId=fab415e33916c, content=<a href='/topic/show?id=28f4125430b' target=_blank style='color:#2F92EE;'>#Nature Communications#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12543, encryptionId=28f4125430b, topicName=Nature Communications)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bea15872676, createdName=qindq, createdTime=Wed Mar 23 04:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1911090, encodeId=3b58191109049, content=<a href='/topic/show?id=8c0d2e73196' target=_blank style='color:#2F92EE;'>#健康人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27731, encryptionId=8c0d2e73196, topicName=健康人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55f6293, createdName=lishizhe, createdTime=Sun Apr 10 22:02:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086852, encodeId=36d520868523f, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Jan 27 01:02:00 CST 2017, time=2017-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903120, encodeId=d10a19031202f, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Sun Jun 12 16:02:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880968, encodeId=aa4d18809684f, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Apr 25 13:02:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489525, encodeId=fcf61489525a7, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Mar 23 04:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573391, encodeId=fab415e33916c, content=<a href='/topic/show?id=28f4125430b' target=_blank style='color:#2F92EE;'>#Nature Communications#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12543, encryptionId=28f4125430b, topicName=Nature Communications)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bea15872676, createdName=qindq, createdTime=Wed Mar 23 04:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=)]

相关资讯

基因编辑工具CRISPR“动物园”欢迎你

Timothy Doran的11岁女儿对鸡蛋过敏。全球约有2%的儿童患有这种病症。像他们一样,Doran的女儿无法接受很多常规疫苗接种,因为它们是利用鸡蛋生产出来的。 身为澳大利亚联邦科学和产业研究组织(CSIRO)分子生物学家的Doran觉得,他能通过强大的基因编辑工具CRISPR-Cas9解决这一问题。大多数鸡蛋过敏是由蛋清中的4种蛋白之一引起的。而当Doran的同事改变了细菌内编码其中

JAD:呼吁科研工作者关注微生物可能是引发老年痴呆的原因

在JAD杂志中发表一篇文章中,超过30名研究人员和临床医生认为,越来越多的研究给我们暗示微生物可能是引发阿兹海默症(AD)的主要病因。尽管,很多证据开始显示出针对微生物的治疗会减缓和阻止AD等神经退行性疾病的恶化。而关于这一方面的研究却被现在关于AD的"主流研究"所掩盖。现在,是时候让我们开始重新评估微生物感染可能是一些神经退行性疾病的主要病因,或至少为原因之一。 他们在文章中特别提到了三种微生

mBio:神奇!首次证实细菌释放挥发物促进真菌生长!

在一项新的研究中,法国研究人员发现一种细菌性病原体释放的挥发性化合物促进囊性纤维化(cystic fibrosis, CF)病人肺部感染中发现的真菌性病原体生长。这一发现首次证实一种病原体通过空气释放信号,从而直接促进另一种病原体生长。相关研究结果发表在2016年3月15日那期mBio期刊上,论文标题为“Volatile Compounds Emit

J Neurosci :用极度饥饿的方式可预防神经退行性变

减少一个人的卡路里摄入量可以预防神经退行性疾病,如帕金森病。但这种现象发生的原因直到现在仍然是个谜。 莫纳什大学生物医学研究所的研究人员Zane Andrews副教授发现这种热量可降低神经保护作用——开放该类药物发展可以在不用减少卡路里摄入的情况下可减缓或防止帕金森等疾病。该研究发表在《神经科学杂志》上。 人类有一种激素称为胃促生长素或“饥饿激素”——在胃肠道产生,作用于大脑用以调节饥饿的

Mol Metabol:饮食多样性降低或影响机体肠道微生物群落的多样性

过去50年里人类耕种方式的改变导致了农作物多样性的降低,从而导致人类饮食多样性的降低,而饮食丰富度的改变对人类健康的明显影响就是如今科学家们非常热衷于研究的课题;近日一项刊登于Molecular Metabolism杂志上的报告中,来自路易斯安那州立大学潘宁顿生物医学研究中心(Pennington Biomedical Research Center)的研究人员就阐明了他们的最新研究成果。

AAC:细菌抗生素耐药性 挥之不去的社会问题

近日,来自纽约大学的研究人员通过研究发现,微量浓度的抗生素或许都足以促进细胞产生抗生素耐药性,研究者表示,这种浓度低于此前他们预期的抗生素浓度,这或可帮助解释为何抗生素耐药性在环境中会持久存在。 抗生素耐药性可以以不同方式来发挥作用,文章中研究者描述了抗生素单一作用及共同作用时耐药性所表现出的不同机制;单一的药物耐受性或许可以使得单一细胞具有耐受性,而共同合作的抗生素耐药性或许使得耐药性细胞及其